Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Narimasa, Kuwabara"'
Autor:
IIchiro Hisatome, Peili Li, Chisato Iwai, Sulistiyati Bayu Utami, Kazuhiko Iitsuka, Masaru Kato, Kazuyoshi Ogura, Yoshiaki Inoue, Akio Yano, Masamitsu Adachi, Narimasa Kuwabara, Sunao Urashima, Yakuang Ting, Junichiro Miake, Osamu Igawa
Publikováno v:
Japanese Journal of Electrocardiology. 30:132-141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70258e57fea72bc9da1ddb487fe280bb
https://doi.org/10.5105/jse.30.132
https://doi.org/10.5105/jse.30.132
Autor:
Yora, Nindita, Toshihiro, Hamada, Udin, Bahrudin, Makoto, Hosoyamada, Kimiyoshi, Ichida, Chisato, Iwai, Sunao, Urashima, Masanari, Kuwabara, Narimasa, Kuwabara, Sulistiyati Bayu, Utami, Einosuke, Mizuta, Kensaku, Yamada, Osamu, Igawa, Chiaki, Shigemasa, Haruaki, Ninomiya, Takuya, Tsuchihashi, Ichiro, Hisatome
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Both an angiotensin II receptor blocker, losartan (CAS 124750-99-8) and a serum urate lowering agent, benzbromarone (CAS 3562-84-3) exert a uricosuric action by inhibiting urate transporter 1 (URAT1). A recent clinical trial indicated that losartan c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf8485ffc2b366c90480ea28c08f9bf
https://doi.org/10.1055/s-0031-1296271
https://doi.org/10.1055/s-0031-1296271
Publikováno v:
Drug Research; Feb2014, Vol. 64 Issue 2, p103-103, 1p